358 South Main Street
LabCorp is a leading global life sciences company. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories.
With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp processes tests on approximately 500,000 specimens each day, applying advances in medicine and science to laboratory testing.
LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 50,000 employees worldwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
132 articles with LabCorp
Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences
LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of COVID-19 Vaccines in Clinical Trials
Quantitative Test is Used to Assess Immune Response and to Support Other Scientific Research
CLEAR, the secure identity company, and LabCorp, a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced a partnership to enable users of CLEAR’s Health Pass mobile app to securely link their LabCorp test results using their LabCorp Patient™ account.
New Heat Extraction Scientific Testing Method and Technology Improves COVID-19 Molecular Test Efficiency and Throughput
The new high-speed test uses a high-throughput method comprising heat and technology to extract RNA from samples used for COVID-19 RT-PCR molecular testing.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
LabCorp and Infirmary Health Form Strategic Partnership to Provide Laboratory Services Across Healthcare System
Multi-year deal will enhance lab services for patients and providers throughout eastern Gulf Coast region
LabCorp (NYSE: LH) will release its third quarter of 2020 financial results before the market opens on Tuesday, Oct. 27, 2020, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results. The earnings release and accompanying financial information will be posted on the LabCorp Investor Relations website . Interested parties can access the conference call by dialing 1-
LabCorp, a leading global life sciences company that is focused on advancing health and guiding patient care decisions, has launched a new, non-invasive test for patients with non-small cell lung cancer.
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with LabCorp’s drug development business, Covance. LabCorp will participate in Tempus's TIME Trial® Network and the companies will work together to accelerate patient enrollment
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
More details of the three-month program will be provided in the near future.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 29, 2020.
LabCorp announced results for the second quarter ended June 30, 2020.
New Method Aims to Improve Efficiency of COVID-19 Testing, Optimize Testing Supplies and Increase Overall Capacity
LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping doctors protect patients by testing them for COVID-19 before surgeries and other important treatments.
LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results
Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients